Drug resistance is an important problem in the treatment of lung cance
r. Patients become resistant not only to the drugs used initially, but
also to those to which they have not yet been exposed. Multiple mecha
nisms contribute to drug resistance in this disease, all or any combin
ation of which may occur simultaneously within each cell, producing on
overall drug resistant phenotype. The limited success of hitherto app
lied strategies in their ability to circumvent drug resistance in lung
cancer suggests that new approaches are required.